Literature DB >> 12093701

Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria.

Ton That Ai Long1, Shusuke Nakazawa, Maria Cecilia Huaman, Hiroji Kanbara.   

Abstract

Antimalarial treatments during primary Plasmodium berghei NK65 infection in BALB/c mice influenced the acquisition of protective immunity against reinfection. Among subcurative treatments, lower doses better enable mice to acquire protective immunity than do higher doses. Eradication of parasites from the start of infection did not promote protective immunity.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12093701      PMCID： PMC120045          DOI： 10.1128/cdli.9.4.933-934.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  9 in total

Review 1.  Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections.

Authors:  T Smith; I Felger; M Tanner; H P Beck
Journal:  Trans R Soc Trop Med Hyg       Date:  1999-02       Impact factor: 2.184

Review 2.  Why is it that antimalarial drug treatments do not always work?

Authors:  N J White
Journal:  Ann Trop Med Parasitol       Date:  1998-06

3.  Malaria immunity and premunition in a Plasmodium berghei mouse model.

Authors:  W M Eling
Journal:  Isr J Med Sci       Date:  1978-05

4.  Plasmodium berghei: isolation and maintenance of an irradiation attenuated strain in the nude mouse.

Authors:  S Waki; J Tamura; M Imanaka; S Ishikawa; M Suzuki
Journal:  Exp Parasitol       Date:  1982-06       Impact factor: 2.011

5.  Chronic Plasmodium falciparum infections in an area of low intensity malaria transmission in the Sudan.

Authors:  A A Hamad; I M El Hassan; A A El Khalifa; G I Ahmed; S A Abdelrahim; T G Theander; D E Arnot
Journal:  Parasitology       Date:  2000-05       Impact factor: 3.234

Review 6.  Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal.

Authors:  C Rogier; A Tall; N Diagne; D Fontenille; A Spiegel; J F Trape
Journal:  Parassitologia       Date:  1999-09

7.  Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar.

Authors:  C Roussilhon; J L Pérignon; P Druilhe
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.184

8.  Active immunization against the malaria parasite Plasmodium berghei in mice: sulfathiazole treatment of a P. berghei infection and development of immunity.

Authors:  W Eling; C Jerusalem
Journal:  Tropenmed Parasitol       Date:  1977-06

9.  A hypothesis about the chronicity of malaria infection.

Authors:  P Druilhe; J L Pérignon
Journal:  Parasitol Today       Date:  1997-09
  9 in total
  6 in total

1.  Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

Authors:  I G Azcárate; P Marín-García; N Camacho; S Pérez-Benavente; A Puyet; A Diez; L Ribas de Pouplana; J M Bautista
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

2.  Piperaquine pharmacodynamics and parasite viability in a murine malaria model.

Authors:  Brioni R Moore; Kenneth F Ilett; Madhu Page-Sharp; Jeffrey D Jago; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

3.  Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45.

Authors:  Diana Haddad; Jorge Maciel; Nirbhay Kumar
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

4.  Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice.

Authors:  Carlos Moneriz; Patricia Marín-García; José M Bautista; Amalia Diez; Antonio Puyet
Journal:  Malar J       Date:  2011-04-25       Impact factor: 2.979

5.  Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum.

Authors:  Aleisha R Brock; Joshua V Ross; Scott Greenhalgh; David P Durham; Alison Galvani; Sunil Parikh; Adrian Esterman
Journal:  Infect Dis Model       Date:  2017-04-15

6.  In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria.

Authors:  Shigeo Suzuki; Kenji Hikosaka; Emmanuel O Balogun; Keisuke Komatsuya; Mamoru Niikura; Fumie Kobayashi; Kiwamu Takahashi; Tohru Tanaka; Motowo Nakajima; Kiyoshi Kita
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.